🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We asked Dr. Alissa Walsh to share her perspective on long-term remission and comprehensive disease control in UC. Watch the video to learn more and follow us for more updates.

Multidisciplinary teams provide a holistic view of UC patients with the great potential it offers but comes with challenges. What strategies do you use to overcome these hurdles in employing multidisciplinary teams for UC?

Watch Prof. Dignass discuss quality of life and importance of managing bowel urgency at ECCO 2025. Follow us for more.

Patients with UC who are in clinical remission may continue to suffer from relapses, underlining the importance of achieving and maintaining long-term remission. How can histologic assessments help in achieving long-term remission in patients with UC?¹,²

What's the latest on the use of new technologies for endoscopic assessment? Watch the video to hear what Dr. Yamile Zabana had to say. Follow us and be part of the conversation.

ECCO 2025 has officially concluded. A huge thank you to everyone who participated! Let’s continue to collaborate, innovate and make a lasting impact in the field of gastroenterology. See you next time!

Faecal biomarkers can serve as indicators of histological inflammation in patients with UC, distinguishing between those in histological remission and those with moderate to severe disease activity. Could they become invaluable tools for the management of patients with UC?

Should routine biopsies be performed in patients with UC who are in endoscopic remission (MES 0-1)?

Going beyond endoscopic remission and aiming for histologic and endoscopic remission is an important goal in UC, as it better predicts future outcomes such as relapse when compared to endoscopic remission alone. How could integrating histology enhance UC management?¹

📈 IBD has no borders, and its prevalence extends across both geographical and personal boundaries.¹ By 2030, its compounded prevalence globally will reach 1 in 100.¹,* This 𝐖𝐨𝐫𝐥𝐝 𝐈𝐁𝐃 𝐃𝐚𝐲, let’s raise awareness on the global impact of IBD. Follow us to learn more.

In patients with UC in endoscopic remission, is it important to consider achieving histologic remission? 𝐅𝐨𝐫 𝐇𝐂𝐏𝐬, 𝐆𝐌-𝟓𝟓𝟓𝟔𝟔. 𝐌𝐚𝐲 𝟐𝟎𝟐𝟓.

How have clinical endpoints for ulcerative colitis patients evolved? Prof. Silvio Danese, a gastroenterologist from Italy, explains. Watch the video.

Clinical remission is key in managing patients with CD, however significant mucosal inflammation can persist despite symptom control—often linked to worse outcomes. How can we more accurately define remission in the management of Crohn’s disease?

A study involving an extensive review of online conversations of patients with UC found that 𝐬𝐭𝐫𝐞𝐬𝐬 𝐚𝐧𝐝 𝐚𝐧𝐱𝐢𝐞𝐭𝐲 were often identified as both triggers and symptoms of flares.* Could routine monitoring of stress and anxiety improve UC management?

Despite achieving clinical remission, 11-27% of patients with CD can experience relapse.* How can addressing 𝐦𝐮𝐜𝐨𝐬𝐚𝐥 𝐢𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐢𝐨𝐧 help improve clinical outcomes in patients with CD?

Deep remission, defined as symptomatic remission with endoscopic healing, is a key goal in UC management.¹ However, over 30% of patients in deep remission have persistent histologic activity.²,* Could histologic assessments in symptom-free patients enhance long-term outcomes?

Among patients with UC in clinical remission, those achieving endoscopic and/or histologic remission had a lower risk of relapse than those achieving clinical remission alone.* Should achieving these more rigorous endpoints be the preferred goal in UC management?

Which diagnostic tool should be prioritised as a first-line test in assessing patients with Crohn's disease? 𝐅𝐨𝐫 𝐇𝐂𝐏𝐬, 𝐆𝐌-𝟓𝟓𝟓𝟔𝟔. 𝐌𝐚𝐲 𝟐𝟎𝟐𝟓.

What do you think is the annual risk of relapse in patients with UC achieving deep remission? 𝐅𝐨𝐫 𝐇𝐂𝐏𝐬, 𝐆𝐌-𝟓𝟓𝟓𝟔𝟔. 𝐌𝐚𝐲 𝟐𝟎𝟐𝟓.

Are endoscopic examinations important in everyday clinical practice while managing patients with CD? 𝐅𝐨𝐫 𝐇𝐂𝐏𝐬, 𝐆𝐌-𝟓𝟓𝟓𝟔𝟔. 𝐌𝐚𝐲 𝟐𝟎𝟐𝟓.